Request for Covid-19 Impact Assessment of this Report
The United States Fexofenadine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Fexofenadine market, reaching US$ million by the year 2028. As for the Europe Fexofenadine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Fexofenadine players cover Viruj Pharma, Cemex Pharma, Smaart Pharmaceutticals, and Titan Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Fexofenadine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Purity:98%
Purity:Above 98%
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hay Fever Treatment
Urticaria Treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Viruj Pharma
Cemex Pharma
Smaart Pharmaceutticals
Titan Pharma
AFCL
Synkromax
Farmhispania
Gen Pharma
Admiron Life Sciences Private Limited
JRC
Archerchem
Sibram
Sumitomo Chemical
Panchsheel
CAMEO HEALTH CARE
CEPiA-Sanofi
Va Sudha Pharma Chem Limited
VPL Chemicals
Zhejiang Excel Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fexofenadine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Fexofenadine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Fexofenadine by Country/Region, 2017, 2022 & 2028
2.2 Fexofenadine Segment by Type
2.2.1 Purity:98%
2.2.2 Purity:Above 98%
2.3 Fexofenadine Sales by Type
2.3.1 Global Fexofenadine Sales Market Share by Type (2017-2022)
2.3.2 Global Fexofenadine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Fexofenadine Sale Price by Type (2017-2022)
2.4 Fexofenadine Segment by Application
2.4.1 Hay Fever Treatment
2.4.2 Urticaria Treatment
2.5 Fexofenadine Sales by Application
2.5.1 Global Fexofenadine Sale Market Share by Application (2017-2022)
2.5.2 Global Fexofenadine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Fexofenadine Sale Price by Application (2017-2022)
3 Global Fexofenadine by Company
3.1 Global Fexofenadine Breakdown Data by Company
3.1.1 Global Fexofenadine Annual Sales by Company (2020-2022)
3.1.2 Global Fexofenadine Sales Market Share by Company (2020-2022)
3.2 Global Fexofenadine Annual Revenue by Company (2020-2022)
3.2.1 Global Fexofenadine Revenue by Company (2020-2022)
3.2.2 Global Fexofenadine Revenue Market Share by Company (2020-2022)
3.3 Global Fexofenadine Sale Price by Company
3.4 Key Manufacturers Fexofenadine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fexofenadine Product Location Distribution
3.4.2 Players Fexofenadine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Fexofenadine by Geographic Region
4.1 World Historic Fexofenadine Market Size by Geographic Region (2017-2022)
4.1.1 Global Fexofenadine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Fexofenadine Annual Revenue by Geographic Region
4.2 World Historic Fexofenadine Market Size by Country/Region (2017-2022)
4.2.1 Global Fexofenadine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Fexofenadine Annual Revenue by Country/Region
4.3 Americas Fexofenadine Sales Growth
4.4 APAC Fexofenadine Sales Growth
4.5 Europe Fexofenadine Sales Growth
4.6 Middle East & Africa Fexofenadine Sales Growth
5 Americas
5.1 Americas Fexofenadine Sales by Country
5.1.1 Americas Fexofenadine Sales by Country (2017-2022)
5.1.2 Americas Fexofenadine Revenue by Country (2017-2022)
5.2 Americas Fexofenadine Sales by Type
5.3 Americas Fexofenadine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fexofenadine Sales by Region
6.1.1 APAC Fexofenadine Sales by Region (2017-2022)
6.1.2 APAC Fexofenadine Revenue by Region (2017-2022)
6.2 APAC Fexofenadine Sales by Type
6.3 APAC Fexofenadine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Fexofenadine by Country
7.1.1 Europe Fexofenadine Sales by Country (2017-2022)
7.1.2 Europe Fexofenadine Revenue by Country (2017-2022)
7.2 Europe Fexofenadine Sales by Type
7.3 Europe Fexofenadine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fexofenadine by Country
8.1.1 Middle East & Africa Fexofenadine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Fexofenadine Revenue by Country (2017-2022)
8.2 Middle East & Africa Fexofenadine Sales by Type
8.3 Middle East & Africa Fexofenadine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fexofenadine
10.3 Manufacturing Process Analysis of Fexofenadine
10.4 Industry Chain Structure of Fexofenadine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fexofenadine Distributors
11.3 Fexofenadine Customer
12 World Forecast Review for Fexofenadine by Geographic Region
12.1 Global Fexofenadine Market Size Forecast by Region
12.1.1 Global Fexofenadine Forecast by Region (2023-2028)
12.1.2 Global Fexofenadine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Fexofenadine Forecast by Type
12.7 Global Fexofenadine Forecast by Application
13 Key Players Analysis
13.1 Viruj Pharma
13.1.1 Viruj Pharma Company Information
13.1.2 Viruj Pharma Fexofenadine Product Offered
13.1.3 Viruj Pharma Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Viruj Pharma Main Business Overview
13.1.5 Viruj Pharma Latest Developments
13.2 Cemex Pharma
13.2.1 Cemex Pharma Company Information
13.2.2 Cemex Pharma Fexofenadine Product Offered
13.2.3 Cemex Pharma Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Cemex Pharma Main Business Overview
13.2.5 Cemex Pharma Latest Developments
13.3 Smaart Pharmaceutticals
13.3.1 Smaart Pharmaceutticals Company Information
13.3.2 Smaart Pharmaceutticals Fexofenadine Product Offered
13.3.3 Smaart Pharmaceutticals Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Smaart Pharmaceutticals Main Business Overview
13.3.5 Smaart Pharmaceutticals Latest Developments
13.4 Titan Pharma
13.4.1 Titan Pharma Company Information
13.4.2 Titan Pharma Fexofenadine Product Offered
13.4.3 Titan Pharma Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Titan Pharma Main Business Overview
13.4.5 Titan Pharma Latest Developments
13.5 AFCL
13.5.1 AFCL Company Information
13.5.2 AFCL Fexofenadine Product Offered
13.5.3 AFCL Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AFCL Main Business Overview
13.5.5 AFCL Latest Developments
13.6 Synkromax
13.6.1 Synkromax Company Information
13.6.2 Synkromax Fexofenadine Product Offered
13.6.3 Synkromax Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Synkromax Main Business Overview
13.6.5 Synkromax Latest Developments
13.7 Farmhispania
13.7.1 Farmhispania Company Information
13.7.2 Farmhispania Fexofenadine Product Offered
13.7.3 Farmhispania Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Farmhispania Main Business Overview
13.7.5 Farmhispania Latest Developments
13.8 Gen Pharma
13.8.1 Gen Pharma Company Information
13.8.2 Gen Pharma Fexofenadine Product Offered
13.8.3 Gen Pharma Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Gen Pharma Main Business Overview
13.8.5 Gen Pharma Latest Developments
13.9 Admiron Life Sciences Private Limited
13.9.1 Admiron Life Sciences Private Limited Company Information
13.9.2 Admiron Life Sciences Private Limited Fexofenadine Product Offered
13.9.3 Admiron Life Sciences Private Limited Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Admiron Life Sciences Private Limited Main Business Overview
13.9.5 Admiron Life Sciences Private Limited Latest Developments
13.10 JRC
13.10.1 JRC Company Information
13.10.2 JRC Fexofenadine Product Offered
13.10.3 JRC Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 JRC Main Business Overview
13.10.5 JRC Latest Developments
13.11 Archerchem
13.11.1 Archerchem Company Information
13.11.2 Archerchem Fexofenadine Product Offered
13.11.3 Archerchem Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Archerchem Main Business Overview
13.11.5 Archerchem Latest Developments
13.12 Sibram
13.12.1 Sibram Company Information
13.12.2 Sibram Fexofenadine Product Offered
13.12.3 Sibram Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sibram Main Business Overview
13.12.5 Sibram Latest Developments
13.13 Sumitomo Chemical
13.13.1 Sumitomo Chemical Company Information
13.13.2 Sumitomo Chemical Fexofenadine Product Offered
13.13.3 Sumitomo Chemical Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Sumitomo Chemical Main Business Overview
13.13.5 Sumitomo Chemical Latest Developments
13.14 Panchsheel
13.14.1 Panchsheel Company Information
13.14.2 Panchsheel Fexofenadine Product Offered
13.14.3 Panchsheel Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Panchsheel Main Business Overview
13.14.5 Panchsheel Latest Developments
13.15 CAMEO HEALTH CARE
13.15.1 CAMEO HEALTH CARE Company Information
13.15.2 CAMEO HEALTH CARE Fexofenadine Product Offered
13.15.3 CAMEO HEALTH CARE Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 CAMEO HEALTH CARE Main Business Overview
13.15.5 CAMEO HEALTH CARE Latest Developments
13.16 CEPiA-Sanofi
13.16.1 CEPiA-Sanofi Company Information
13.16.2 CEPiA-Sanofi Fexofenadine Product Offered
13.16.3 CEPiA-Sanofi Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 CEPiA-Sanofi Main Business Overview
13.16.5 CEPiA-Sanofi Latest Developments
13.17 Va Sudha Pharma Chem Limited
13.17.1 Va Sudha Pharma Chem Limited Company Information
13.17.2 Va Sudha Pharma Chem Limited Fexofenadine Product Offered
13.17.3 Va Sudha Pharma Chem Limited Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Va Sudha Pharma Chem Limited Main Business Overview
13.17.5 Va Sudha Pharma Chem Limited Latest Developments
13.18 VPL Chemicals
13.18.1 VPL Chemicals Company Information
13.18.2 VPL Chemicals Fexofenadine Product Offered
13.18.3 VPL Chemicals Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 VPL Chemicals Main Business Overview
13.18.5 VPL Chemicals Latest Developments
13.19 Zhejiang Excel Pharmaceutical
13.19.1 Zhejiang Excel Pharmaceutical Company Information
13.19.2 Zhejiang Excel Pharmaceutical Fexofenadine Product Offered
13.19.3 Zhejiang Excel Pharmaceutical Fexofenadine Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Zhejiang Excel Pharmaceutical Main Business Overview
13.19.5 Zhejiang Excel Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Fexofenadine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Fexofenadine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Purity:98%
Table 4. Major Players of Purity:Above 98%
Table 5. Global Fexofenadine Sales by Type (2017-2022) & (MT)
Table 6. Global Fexofenadine Sales Market Share by Type (2017-2022)
Table 7. Global Fexofenadine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Fexofenadine Revenue Market Share by Type (2017-2022)
Table 9. Global Fexofenadine Sale Price by Type (2017-2022) & (USD/MT)
Table 10. Global Fexofenadine Sales by Application (2017-2022) & (MT)
Table 11. Global Fexofenadine Sales Market Share by Application (2017-2022)
Table 12. Global Fexofenadine Revenue by Application (2017-2022)
Table 13. Global Fexofenadine Revenue Market Share by Application (2017-2022)
Table 14. Global Fexofenadine Sale Price by Application (2017-2022) & (USD/MT)
Table 15. Global Fexofenadine Sales by Company (2020-2022) & (MT)
Table 16. Global Fexofenadine Sales Market Share by Company (2020-2022)
Table 17. Global Fexofenadine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Fexofenadine Revenue Market Share by Company (2020-2022)
Table 19. Global Fexofenadine Sale Price by Company (2020-2022) & (USD/MT)
Table 20. Key Manufacturers Fexofenadine Producing Area Distribution and Sales Area
Table 21. Players Fexofenadine Products Offered
Table 22. Fexofenadine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Fexofenadine Sales by Geographic Region (2017-2022) & (MT)
Table 26. Global Fexofenadine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Fexofenadine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Fexofenadine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Fexofenadine Sales by Country/Region (2017-2022) & (MT)
Table 30. Global Fexofenadine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Fexofenadine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Fexofenadine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Fexofenadine Sales by Country (2017-2022) & (MT)
Table 34. Americas Fexofenadine Sales Market Share by Country (2017-2022)
Table 35. Americas Fexofenadine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Fexofenadine Revenue Market Share by Country (2017-2022)
Table 37. Americas Fexofenadine Sales by Type (2017-2022) & (MT)
Table 38. Americas Fexofenadine Sales Market Share by Type (2017-2022)
Table 39. Americas Fexofenadine Sales by Application (2017-2022) & (MT)
Table 40. Americas Fexofenadine Sales Market Share by Application (2017-2022)
Table 41. APAC Fexofenadine Sales by Region (2017-2022) & (MT)
Table 42. APAC Fexofenadine Sales Market Share by Region (2017-2022)
Table 43. APAC Fexofenadine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Fexofenadine Revenue Market Share by Region (2017-2022)
Table 45. APAC Fexofenadine Sales by Type (2017-2022) & (MT)
Table 46. APAC Fexofenadine Sales Market Share by Type (2017-2022)
Table 47. APAC Fexofenadine Sales by Application (2017-2022) & (MT)
Table 48. APAC Fexofenadine Sales Market Share by Application (2017-2022)
Table 49. Europe Fexofenadine Sales by Country (2017-2022) & (MT)
Table 50. Europe Fexofenadine Sales Market Share by Country (2017-2022)
Table 51. Europe Fexofenadine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Fexofenadine Revenue Market Share by Country (2017-2022)
Table 53. Europe Fexofenadine Sales by Type (2017-2022) & (MT)
Table 54. Europe Fexofenadine Sales Market Share by Type (2017-2022)
Table 55. Europe Fexofenadine Sales by Application (2017-2022) & (MT)
Table 56. Europe Fexofenadine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Fexofenadine Sales by Country (2017-2022) & (MT)
Table 58. Middle East & Africa Fexofenadine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Fexofenadine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Fexofenadine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Fexofenadine Sales by Type (2017-2022) & (MT)
Table 62. Middle East & Africa Fexofenadine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Fexofenadine Sales by Application (2017-2022) & (MT)
Table 64. Middle East & Africa Fexofenadine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Fexofenadine
Table 66. Key Market Challenges & Risks of Fexofenadine
Table 67. Key Industry Trends of Fexofenadine
Table 68. Fexofenadine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Fexofenadine Distributors List
Table 71. Fexofenadine Customer List
Table 72. Global Fexofenadine Sales Forecast by Region (2023-2028) & (MT)
Table 73. Global Fexofenadine Sales Market Forecast by Region
Table 74. Global Fexofenadine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Fexofenadine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Fexofenadine Sales Forecast by Country (2023-2028) & (MT)
Table 77. Americas Fexofenadine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Fexofenadine Sales Forecast by Region (2023-2028) & (MT)
Table 79. APAC Fexofenadine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Fexofenadine Sales Forecast by Country (2023-2028) & (MT)
Table 81. Europe Fexofenadine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Fexofenadine Sales Forecast by Country (2023-2028) & (MT)
Table 83. Middle East & Africa Fexofenadine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Fexofenadine Sales Forecast by Type (2023-2028) & (MT)
Table 85. Global Fexofenadine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Fexofenadine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Fexofenadine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Fexofenadine Sales Forecast by Application (2023-2028) & (MT)
Table 89. Global Fexofenadine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Fexofenadine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Fexofenadine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Viruj Pharma Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 93. Viruj Pharma Fexofenadine Product Offered
Table 94. Viruj Pharma Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 95. Viruj Pharma Main Business
Table 96. Viruj Pharma Latest Developments
Table 97. Cemex Pharma Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 98. Cemex Pharma Fexofenadine Product Offered
Table 99. Cemex Pharma Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 100. Cemex Pharma Main Business
Table 101. Cemex Pharma Latest Developments
Table 102. Smaart Pharmaceutticals Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 103. Smaart Pharmaceutticals Fexofenadine Product Offered
Table 104. Smaart Pharmaceutticals Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 105. Smaart Pharmaceutticals Main Business
Table 106. Smaart Pharmaceutticals Latest Developments
Table 107. Titan Pharma Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 108. Titan Pharma Fexofenadine Product Offered
Table 109. Titan Pharma Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 110. Titan Pharma Main Business
Table 111. Titan Pharma Latest Developments
Table 112. AFCL Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 113. AFCL Fexofenadine Product Offered
Table 114. AFCL Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 115. AFCL Main Business
Table 116. AFCL Latest Developments
Table 117. Synkromax Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 118. Synkromax Fexofenadine Product Offered
Table 119. Synkromax Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 120. Synkromax Main Business
Table 121. Synkromax Latest Developments
Table 122. Farmhispania Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 123. Farmhispania Fexofenadine Product Offered
Table 124. Farmhispania Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 125. Farmhispania Main Business
Table 126. Farmhispania Latest Developments
Table 127. Gen Pharma Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 128. Gen Pharma Fexofenadine Product Offered
Table 129. Gen Pharma Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 130. Gen Pharma Main Business
Table 131. Gen Pharma Latest Developments
Table 132. Admiron Life Sciences Private Limited Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 133. Admiron Life Sciences Private Limited Fexofenadine Product Offered
Table 134. Admiron Life Sciences Private Limited Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 135. Admiron Life Sciences Private Limited Main Business
Table 136. Admiron Life Sciences Private Limited Latest Developments
Table 137. JRC Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 138. JRC Fexofenadine Product Offered
Table 139. JRC Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 140. JRC Main Business
Table 141. JRC Latest Developments
Table 142. Archerchem Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 143. Archerchem Fexofenadine Product Offered
Table 144. Archerchem Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 145. Archerchem Main Business
Table 146. Archerchem Latest Developments
Table 147. Sibram Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 148. Sibram Fexofenadine Product Offered
Table 149. Sibram Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 150. Sibram Main Business
Table 151. Sibram Latest Developments
Table 152. Sumitomo Chemical Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 153. Sumitomo Chemical Fexofenadine Product Offered
Table 154. Sumitomo Chemical Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 155. Sumitomo Chemical Main Business
Table 156. Sumitomo Chemical Latest Developments
Table 157. Panchsheel Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 158. Panchsheel Fexofenadine Product Offered
Table 159. Panchsheel Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 160. Panchsheel Main Business
Table 161. Panchsheel Latest Developments
Table 162. CAMEO HEALTH CARE Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 163. CAMEO HEALTH CARE Fexofenadine Product Offered
Table 164. CAMEO HEALTH CARE Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 165. CAMEO HEALTH CARE Main Business
Table 166. CAMEO HEALTH CARE Latest Developments
Table 167. CEPiA-Sanofi Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 168. CEPiA-Sanofi Fexofenadine Product Offered
Table 169. CEPiA-Sanofi Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 170. CEPiA-Sanofi Main Business
Table 171. CEPiA-Sanofi Latest Developments
Table 172. Va Sudha Pharma Chem Limited Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 173. Va Sudha Pharma Chem Limited Fexofenadine Product Offered
Table 174. Va Sudha Pharma Chem Limited Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 175. Va Sudha Pharma Chem Limited Main Business
Table 176. Va Sudha Pharma Chem Limited Latest Developments
Table 177. VPL Chemicals Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 178. VPL Chemicals Fexofenadine Product Offered
Table 179. VPL Chemicals Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 180. VPL Chemicals Main Business
Table 181. VPL Chemicals Latest Developments
Table 182. Zhejiang Excel Pharmaceutical Basic Information, Fexofenadine Manufacturing Base, Sales Area and Its Competitors
Table 183. Zhejiang Excel Pharmaceutical Fexofenadine Product Offered
Table 184. Zhejiang Excel Pharmaceutical Fexofenadine Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 185. Zhejiang Excel Pharmaceutical Main Business
Table 186. Zhejiang Excel Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Fexofenadine
Figure 2. Fexofenadine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fexofenadine Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Fexofenadine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Fexofenadine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Purity:98%
Figure 10. Product Picture of Purity:Above 98%
Figure 11. Global Fexofenadine Sales Market Share by Type in 2021
Figure 12. Global Fexofenadine Revenue Market Share by Type (2017-2022)
Figure 13. Fexofenadine Consumed in Hay Fever Treatment
Figure 14. Global Fexofenadine Market: Hay Fever Treatment (2017-2022) & (MT)
Figure 15. Fexofenadine Consumed in Urticaria Treatment
Figure 16. Global Fexofenadine Market: Urticaria Treatment (2017-2022) & (MT)
Figure 17. Global Fexofenadine Sales Market Share by Application (2017-2022)
Figure 18. Global Fexofenadine Revenue Market Share by Application in 2021
Figure 19. Fexofenadine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Fexofenadine Revenue Market Share by Company in 2021
Figure 21. Global Fexofenadine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Fexofenadine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Fexofenadine Sales Market Share by Region (2017-2022)
Figure 24. Global Fexofenadine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Fexofenadine Sales 2017-2022 (MT)
Figure 26. Americas Fexofenadine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Fexofenadine Sales 2017-2022 (MT)
Figure 28. APAC Fexofenadine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Fexofenadine Sales 2017-2022 (MT)
Figure 30. Europe Fexofenadine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Fexofenadine Sales 2017-2022 (MT)
Figure 32. Middle East & Africa Fexofenadine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Fexofenadine Sales Market Share by Country in 2021
Figure 34. Americas Fexofenadine Revenue Market Share by Country in 2021
Figure 35. United States Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Fexofenadine Sales Market Share by Region in 2021
Figure 40. APAC Fexofenadine Revenue Market Share by Regions in 2021
Figure 41. China Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Fexofenadine Sales Market Share by Country in 2021
Figure 48. Europe Fexofenadine Revenue Market Share by Country in 2021
Figure 49. Germany Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Fexofenadine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Fexofenadine Revenue Market Share by Country in 2021
Figure 56. Egypt Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Fexofenadine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Fexofenadine in 2021
Figure 62. Manufacturing Process Analysis of Fexofenadine
Figure 63. Industry Chain Structure of Fexofenadine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...